If confirmed as head of the Department of Health and Human Services, Kennedy could influence U.S. policy on vaccines, drugs and food safety.

Friday was a doozy for many biotech and pharmaceutical companies after news broke late Thursday that President-elect Donald Trump would nominate vaccine skeptic Robert F. Kennedy Jr. to the nation's ...

Vaccine and other healthcare stocks retreated sharply on Friday after RFK was selected to lead the US health and human ...

Robert F. Kennedy's Jr. push to remove fluoride from the nation's public water supply could benefit some companies. Here's ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

Trump announced Thursday he’ll nominate Robert F. Kennedy Jr. to be secretary of the Health and Human Services Department.

The announcement of Robert F. Kennedy Jr. as President-elect Donald Trumps pick for Secretary of Health and Human Services ...

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

HHS houses major health agencies in the U.S., like the FDA, the CDC and the NIH, and it’s also responsible for Medicare and ...